Dimitrios Iliopoulos

19.4k citations
243 papers · 15.8k indexed · 8 hit papers · h-index 59
Topics
Aortic Disease and Treatment Approaches (40 papers)MicroRNA in disease regulation (35 papers)Aortic aneurysm repair treatments (30 papers)
Partner nations
United StatesGreeceItaly

In The Last Decade

Dimitrios Iliopoulos

234 papers receiving 15.5k citations

Hit Papers

An Epigenetic Switch Involving NF-κB, Lin28, Let-7 MicroR...2008202620142020200920092008201020172505007501000

Peers

Dimitrios Iliopoulos
Comparison fields: 5 of 158
  • Molecular Biology 8.9k
  • Cancer Research 5.5k
  • Oncology 3.2k
  • Pulmonary and Respiratory Medicine 2.3k
  • Immunology 2.2k
Replace Masabumi Shibuya with:
Masabumi Shibuya Japan
Guo‐Ping Shi United States
Denis C. Guttridge United States
Jian Wang China
Xiao‐Ming Meng China
Hidenori Koyama Japan
David J. Loskutoff United States
Roy L. Silverstein United States
Désiré Collen Belgium
Maria Tsokos United States
Dimitrios Iliopoulos relative to Masabumi Shibuya Japan Masabumi Shibuya's profile →
Citations per field
00.5×1.5×
Masabumi Shibuya · 1×
Citations per year

Countries citing papers authored by Dimitrios Iliopoulos

Since Specialization
Citations

This map shows the geographic impact of Dimitrios Iliopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dimitrios Iliopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dimitrios Iliopoulos more than expected).

Fields of papers citing papers by Dimitrios Iliopoulos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dimitrios Iliopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dimitrios Iliopoulos. The network helps show where Dimitrios Iliopoulos may publish in the future.

Co-authorship network of co-authors of Dimitrios Iliopoulos

This figure shows the co-authorship network connecting the top 25 collaborators of Dimitrios Iliopoulos. A scholar is included among the top collaborators of Dimitrios Iliopoulos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dimitrios Iliopoulos. Dimitrios Iliopoulos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 0
4 0
5 4
6 28
7 6
8 6
9 49
10 5
11 19
12 5
13 13
14 374
15 75
16 59
17
Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remissionbreakdown →
903
18 74
19 90
20 37

About Dimitrios Iliopoulos

Dimitrios Iliopoulos is a scholar working on Cancer Research, Cardiology and Cardiovascular Medicine and Immunology, having authored 243 papers that have together received 15.8k indexed citations. Recurring topics across this work include Aortic Disease and Treatment Approaches (40 papers), MicroRNA in disease regulation (35 papers) and Aortic aneurysm repair treatments (30 papers). The work is most often cited by research in Cancer Research (5.5k citations), Molecular Biology (8.9k citations) and Oncology (3.2k citations). Dimitrios Iliopoulos has collaborated with scholars based in United States, Greece and Italy. Frequent co-authors include Kevin Struhl, Heather A. Hirsch, Philip N. Tsichlis, Christos Polytarchou, Aspasia Tsezou, Savina Jaeger, Maria Hatziapostolou, Κonstantinos Ν. Malizos, Martha L. Bulyk and Hazim J. Safi. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026